Riverhead Capital Management LLC boosted its stake in Stryker Co. (NYSE:SYK) by 12.4% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 14,479 shares of the medical technology company’s stock after acquiring an additional 1,598 shares during the period. Riverhead Capital Management LLC’s holdings in Stryker were worth $2,860,000 as of its most recent SEC filing.
A number of other hedge funds also recently modified their holdings of SYK. Buckingham Capital Management Inc. lifted its stake in Stryker by 8.5% in the fourth quarter. Buckingham Capital Management Inc. now owns 30,630 shares of the medical technology company’s stock worth $4,801,000 after acquiring an additional 2,391 shares during the period. Capital Investment Advisory Services LLC bought a new position in Stryker in the fourth quarter worth $46,000. Fishman Jay A Ltd. MI raised its holdings in Stryker by 0.3% in the fourth quarter. Fishman Jay A Ltd. MI now owns 65,380 shares of the medical technology company’s stock worth $10,248,000 after purchasing an additional 210 shares in the last quarter. Oregon Public Employees Retirement Fund raised its holdings in Stryker by 8,029.5% in the fourth quarter. Oregon Public Employees Retirement Fund now owns 6,075,473 shares of the medical technology company’s stock worth $39,000 after purchasing an additional 6,000,739 shares in the last quarter. Finally, WINTON GROUP Ltd raised its holdings in Stryker by 120.2% in the fourth quarter. WINTON GROUP Ltd now owns 3,874 shares of the medical technology company’s stock worth $607,000 after purchasing an additional 2,115 shares in the last quarter. Hedge funds and other institutional investors own 73.61% of the company’s stock.
A number of equities analysts have issued reports on the company. Zacks Investment Research upgraded Stryker from a “hold” rating to a “buy” rating and set a $206.00 price objective for the company in a report on Tuesday. ValuEngine upgraded Stryker from a “hold” rating to a “buy” rating in a report on Friday, May 3rd. Oppenheimer increased their price objective on Stryker from $183.00 to $192.00 and gave the stock an “outperform” rating in a report on Wednesday, April 24th. Robert W. Baird increased their price objective on Stryker from $201.00 to $206.00 and gave the stock an “outperform” rating in a report on Wednesday, April 24th. Finally, Deutsche Bank increased their price objective on Stryker from $181.00 to $208.00 and gave the stock a “buy” rating in a report on Wednesday, April 24th. Six equities research analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the stock. The company currently has an average rating of “Buy” and an average price target of $196.75.
Stryker stock opened at $195.47 on Friday. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.30 and a current ratio of 2.12. Stryker Co. has a one year low of $144.75 and a one year high of $199.85. The firm has a market cap of $73.42 billion, a P/E ratio of 26.74, a price-to-earnings-growth ratio of 2.40 and a beta of 0.81.
Stryker (NYSE:SYK) last released its quarterly earnings data on Tuesday, April 23rd. The medical technology company reported $1.88 EPS for the quarter, beating the consensus estimate of $1.84 by $0.04. Stryker had a return on equity of 26.72% and a net margin of 25.38%. The company had revenue of $3.52 billion for the quarter, compared to analysts’ expectations of $3.51 billion. During the same period last year, the firm posted $1.68 earnings per share. Stryker’s revenue was up 8.5% compared to the same quarter last year. As a group, equities analysts anticipate that Stryker Co. will post 8.15 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 31st. Investors of record on Friday, June 28th will be given a dividend of $0.52 per share. The ex-dividend date of this dividend is Thursday, June 27th. This represents a $2.08 annualized dividend and a dividend yield of 1.06%. Stryker’s dividend payout ratio (DPR) is presently 28.45%.
In other Stryker news, insider Timothy J. Scannell sold 4,666 shares of the firm’s stock in a transaction dated Monday, March 18th. The stock was sold at an average price of $193.28, for a total value of $901,844.48. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Chairman Kevin Lobo sold 41,750 shares of the firm’s stock in a transaction dated Monday, March 25th. The stock was sold at an average price of $194.11, for a total value of $8,104,092.50. The disclosure for this sale can be found here. Insiders have sold 82,303 shares of company stock worth $15,947,489 over the last ninety days. 7.20% of the stock is currently owned by insiders.
ILLEGAL ACTIVITY WARNING: “Stryker Co. (NYSE:SYK) Shares Bought by Riverhead Capital Management LLC” was posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this report on another publication, it was stolen and republished in violation of United States & international copyright and trademark laws. The correct version of this report can be viewed at https://www.dispatchtribunal.com/2019/06/15/stryker-co-nysesyk-shares-bought-by-riverhead-capital-management-llc.html.
Stryker Company Profile
Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical devices for use in various medical specialties.
Read More: What is the NASDAQ Stock Market?
Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Co. (NYSE:SYK).
Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.